These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methoxy-derivatization of alkyl chains increases the in vivo efficacy of cationic Mn porphyrins. Synthesis, characterization, SOD-like activity, and SOD-deficient E. coli study of meta Mn(III) N-methoxyalkylpyridylporphyrins. Tovmasyan AG; Rajic Z; Spasojevic I; Reboucas JS; Chen X; Salvemini D; Sheng H; Warner DS; Benov L; Batinic-Haberle I Dalton Trans; 2011 Apr; 40(16):4111-21. PubMed ID: 21384047 [TBL] [Abstract][Full Text] [Related]
3. Robust rat pulmonary radioprotection by a lipophilic Mn N-alkylpyridylporphyrin, MnTnHex-2-PyP(5+). Gauter-Fleckenstein B; Reboucas JS; Fleckenstein K; Tovmasyan A; Owzar K; Jiang C; Batinic-Haberle I; Vujaskovic Z Redox Biol; 2014; 2():400-10. PubMed ID: 24624330 [TBL] [Abstract][Full Text] [Related]
4. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142 [TBL] [Abstract][Full Text] [Related]
5. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+. Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731 [TBL] [Abstract][Full Text] [Related]
7. A new SOD mimic, Mn(III) ortho N-butoxyethylpyridylporphyrin, combines superb potency and lipophilicity with low toxicity. Rajic Z; Tovmasyan A; Spasojevic I; Sheng H; Lu M; Li AM; Gralla EB; Warner DS; Benov L; Batinic-Haberle I Free Radic Biol Med; 2012 May; 52(9):1828-34. PubMed ID: 22336516 [TBL] [Abstract][Full Text] [Related]
8. Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins. Kos I; Rebouças JS; DeFreitas-Silva G; Salvemini D; Vujaskovic Z; Dewhirst MW; Spasojević I; Batinić-Haberle I Free Radic Biol Med; 2009 Jul; 47(1):72-8. PubMed ID: 19361553 [TBL] [Abstract][Full Text] [Related]
9. Intracellular targeting and pharmacological activity of the superoxide dismutase mimics MnTE-2-PyP5+ and MnTnHex-2-PyP5+ regulated by their porphyrin ring substituents. Aitken JB; Shearer EL; Giles NM; Lai B; Vogt S; Reboucas JS; Batinic-Haberle I; Lay PA; Giles GI Inorg Chem; 2013 Apr; 52(8):4121-3. PubMed ID: 23551184 [TBL] [Abstract][Full Text] [Related]
10. Quality of potent Mn porphyrin-based SOD mimics and peroxynitrite scavengers for pre-clinical mechanistic/therapeutic purposes. Rebouças JS; Spasojević I; Batinić-Haberle I J Pharm Biomed Anal; 2008 Nov; 48(3):1046-9. PubMed ID: 18804338 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP. Shin SW; Choi C; Lee GH; Son A; Kim SH; Park HC; Batinic-Haberle I; Park W Antioxid Redox Signal; 2017 Nov; 27(14):1067-1082. PubMed ID: 28358581 [TBL] [Abstract][Full Text] [Related]
12. Manganese porphyrin redox state in endothelial cells: Resonance Raman studies and implications for antioxidant protection towards peroxynitrite. Carballal S; Valez V; Alvarez-Paggi D; Tovmasyan A; Batinic-Haberle I; Ferrer-Sueta G; Murgida DH; Radi R Free Radic Biol Med; 2018 Oct; 126():379-392. PubMed ID: 30144631 [TBL] [Abstract][Full Text] [Related]
13. Effects of MnTnHex-2-PyP on lung antioxidant defence system in asthma mice model. Dancheva V; Terziev L; Shopova V; Stavreva G Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):329-35. PubMed ID: 23264410 [TBL] [Abstract][Full Text] [Related]
14. High lipophilicity of meta Mn(III) N-alkylpyridylporphyrin-based superoxide dismutase mimics compensates for their lower antioxidant potency and makes them as effective as ortho analogues in protecting superoxide dismutase-deficient Escherichia coli. Kos I; Benov L; Spasojević I; Rebouças JS; Batinić-Haberle I J Med Chem; 2009 Dec; 52(23):7868-72. PubMed ID: 19954250 [TBL] [Abstract][Full Text] [Related]
15. Analysis of radiation-induced apoptosis in human lymphocytes: flow cytometry using Annexin V and propidium iodide versus the neutral comet assay. Wilkins RC; Kutzner BC; Truong M; Sanchez-Dardon J; McLean JR Cytometry; 2002 May; 48(1):14-9. PubMed ID: 12116376 [TBL] [Abstract][Full Text] [Related]
16. Differential localization and potency of manganese porphyrin superoxide dismutase-mimicking compounds in Saccharomyces cerevisiae. Li AM; Martins J; Tovmasyan A; Valentine JS; Batinic-Haberle I; Spasojevic I; Gralla EB Redox Biol; 2014; 3():1-6. PubMed ID: 25462059 [TBL] [Abstract][Full Text] [Related]
17. Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity. Okado-Matsumoto A; Batinić-Haberle I; Fridovich I Free Radic Biol Med; 2004 Aug; 37(3):401-10. PubMed ID: 15223074 [TBL] [Abstract][Full Text] [Related]
18. Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways. Batinić-Haberle I; Ndengele MM; Cuzzocrea S; Rebouças JS; Spasojević I; Salvemini D Free Radic Biol Med; 2009 Jan; 46(2):212-9. PubMed ID: 18983908 [TBL] [Abstract][Full Text] [Related]
19. Redox modulation of oxidative stress by Mn porphyrin-based therapeutics: the effect of charge distribution. Rebouças JS; Spasojević I; Tjahjono DH; Richaud A; Méndez F; Benov L; Batinić-Haberle I Dalton Trans; 2008 Mar; (9):1233-42. PubMed ID: 18283384 [TBL] [Abstract][Full Text] [Related]
20. New class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins. Batinić-Haberle I; Spasojević I; Stevens RD; Hambright P; Neta P; Okado-Matsumoto A; Fridovich I Dalton Trans; 2004 Jun; (11):1696-702. PubMed ID: 15252564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]